Early research (Phase 1)WithdrawnNCT07566585
What this trial is testing
Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation
Who this might be right for
AML - Acute Myeloid LeukemiaAML With Mutated NPM1AML, Adult Recurrent
BlueSphere Bio, Inc